NASDAQ:IART • US4579852082
Past quarterly earnings results for INTEGRA LIFESCIENCES HOLDING (IART), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.83 | 0.82 | 1.67% | -14.43% | 434.925M | 438.21M | -0.75% | -1.74% |
| Q3 2025 | 0.54 | 0.44 | 21.70% | 31.71% | 402.062M | 422.54M | -4.85% | 5.57% |
| Q2 2025 | 0.45 | 0.44 | 2.22% | -28.57% | 415.605M | 402.97M | 3.14% | -0.61% |
| Q1 2025 | 0.41 | 0.44 | -6.76% | -25.45% | 382.653M | 388.79M | -1.58% | 3.74% |
| Q4 2024 | 0.97 | 0.87 | 11.12% | 8.99% | 442.645M | 454.06M | -2.51% | 11.49% |
| Q3 2024 | 0.41 | 0.40 | 3.22% | -46.05% | 380.834M | 383.3M | -0.64% | -0.93% |
| Q2 2024 | 0.63 | 0.64 | -0.79% | -11.27% | 418.175M | 421.42M | -0.77% | 9.68% |
| Q1 2024 | 0.55 | 0.56 | -2.26% | -25.68% | 368.872M | 369.2M | -0.09% | -3.14% |
| Q4 2023 | 0.89 | 0.92 | -3.39% | -5.32% | 397.039M | 407.32M | -2.52% | -0.24% |
| Q3 2023 | 0.76 | 0.79 | -4.22% | -11.63% | 384.421M | 394.87M | -2.65% | -0.20% |
| Q2 2023 | 0.71 | 0.58 | 22.31% | -12.35% | 381.267M | 381.55M | -0.07% | -4.16% |
| Q1 2023 | 0.74 | 0.75 | -1.54% | - | 380.846M | 380.68M | 0.04% | 1.13% |
| Q4 2022 | 0.94 | 0.92 | 2.05% | 11.90% | 398M | 405.91M | -1.95% | -1.85% |
| Q3 2022 | 0.86 | 0.73 | 17.19% | - | 385.2M | 385.88M | -0.18% | -0.44% |
| Q2 2022 | 0.81 | 0.81 | -0.43% | 2.53% | 397.8M | 403.17M | -1.33% | 2.00% |
| Q1 2022 | 0.74 | 0.69 | 6.68% | 7.25% | 376.6M | 369.28M | 1.98% | 4.58% |
| Q4 2021 | 0.84 | 0.85 | -1.23% | - | 405.5M | 411.47M | -1.45% | 4.35% |
| Q3 2021 | 0.86 | 0.74 | 16.42% | 7.50% | 386.9M | 392.27M | -1.37% | 4.51% |
| Q2 2021 | 0.79 | 0.67 | 17.55% | 139.39% | 390M | 383.6M | 1.67% | 50.75% |
| Q1 2021 | 0.69 | 0.58 | 19.58% | 43.75% | 360.1M | 356.81M | 0.92% | 1.64% |
| Q4 2020 | 0.84 | 0.74 | 12.91% | - | 388.6M | 396.35M | -1.96% | - |
| Q3 2020 | 0.80 | 0.55 | 44.46% | - | 370.2M | 357.06M | 3.68% | - |
| Q2 2020 | 0.33 | 0.10 | 224.34% | - | 258.7M | 247.66M | 4.46% | - |
| Q1 2020 | 0.48 | 0.65 | -25.66% | - | 354.3M | 369.11M | -4.01% | - |
Notes
INTEGRA LIFESCIENCES HOLDING (IART) last reported earnings on 2/26/2026.
INTEGRA LIFESCIENCES HOLDING (IART) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, INTEGRA LIFESCIENCES HOLDING (IART) has beaten EPS estimates in 3 out of 4 releases.